The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC)

被引:2
|
作者
Malgundkar, Shika Hanif [1 ]
Tamimi, Yahya [1 ]
机构
[1] Sultan Qaboos Univ, Coll Med & Hlth Sci, Biochem Dept, POB 35, Muscat 123, Oman
关键词
PACLITAXEL RESISTANCE; CISPLATIN RESISTANCE; MOLECULAR-MECHANISMS; EXPRESSION; LNCRNA; GENE; CELLS; ANNOTATION; DATABASE; GENOME;
D O I
10.1007/s00439-023-02635-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ovarian cancer (OC) is a fatal gynecological disease that is often diagnosed at later stages due to its asymptomatic nature and the absence of efficient early-stage biomarkers. Previous studies have identified genes with abnormal expression in OC that couldn't be explained by methylation or mutation, indicating alternative mechanisms of gene regulation. Recent advances in human transcriptome studies have led to research on non-coding RNAs (ncRNAs) as regulators of cancer gene expression. Long non-coding RNAs (lncRNAs), a class of ncRNAs with a length greater than 200 nucleotides, have been identified as crucial regulators of physiological processes and human diseases, including cancer. Dysregulated lncRNA expression has also been found to play a crucial role in ovarian carcinogenesis, indicating their potential as novel and non-invasive biomarkers for improving OC management. However, despite the discovery of several thousand lncRNAs, only one has been approved for clinical use as a biomarker in cancer, highlighting the importance of further research in this field. In addition to their potential as biomarkers, lncRNAs have been implicated in modulating chemoresistance, a major problem in OC. Several studies have identified altered lncRNA expression upon drug treatment, further emphasizing their potential to modulate chemoresistance. In this review, we highlight the characteristics of lncRNAs, their function, and their potential to serve as tumor markers in OC. We also discuss a few databases providing detailed information on lncRNAs in various cancer types. Despite the promising potential of lncRNAs, further research is necessary to fully understand their role in cancer and develop effective strategies to combat this devastating disease.
引用
收藏
页码:107 / 124
页数:18
相关论文
共 50 条
  • [21] Potentials of long non-coding RNAs as biomarkers of colorectal cancer
    Lv, Yan
    Wang, Yanhua
    Zhang, Zhikai
    Bao, Jiarui
    Su, Huahua
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (09): : 1715 - 1731
  • [22] Potentials of long non-coding RNAs as biomarkers of colorectal cancer
    Yan Lv
    Yanhua Wang
    Zhikai Zhang
    Jiarui Bao
    Huahua Su
    Clinical and Translational Oncology, 2022, 24 : 1715 - 1731
  • [23] Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers
    Li, Yongxing
    Tang, Xiaoqi
    Wang, Binpan
    Chen, Ming
    Zheng, Ji
    Chang, Kai
    NON-CODING RNA RESEARCH, 2024, 9 (04): : 1351 - 1362
  • [24] Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
    Gupta, Subash Chandra
    Tripathi, Yashoda Nandan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (09) : 1955 - 1967
  • [25] Long non-coding RNAs: A view to kill ovarian cancer
    Zamaraev, Alexey, V
    Volik, Pavel, I
    Sukhikh, Gennady T.
    Kopeina, Gelina S.
    Zhivotovsky, Boris
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [26] Long non-coding RNAs and gastric cancer: An update of potential biomarkers and therapeutic applications
    Hosseini, Sayedeh Azimeh
    Haddadi, Mohammad Hossein
    Fathizadeh, Hadis
    Nemati, Foroogh
    Aznaveh, Hooman Mahmoudi
    Taraj, Farima
    Aghabozorgizadeh, AmirArsalan
    Gandomkar, Golmaryam
    Bazazzadeh, Elaheh
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [27] Role of Long Non-coding RNAs on Bladder Cancer
    Li, Hui-Jin
    Gong, Xue
    Li, Zheng-Kun
    Qin, Wei
    He, Chun-Xia
    Xing, Lu
    Zhou, Xin
    Zhao, Dong
    Cao, Hui-Ling
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [28] The Role of Long Non-Coding RNAs in Thyroid Cancer
    Peng, Xuejiao
    Zhang, Kun
    Ma, Li
    Xu, Junfeng
    Chang, Weiqin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] The Role of Long Non-Coding RNAs in Breast Cancer
    Soudyab, Mohammad
    Iranpour, Mostafa
    Ghafouri-Fard, Soudeh
    ARCHIVES OF IRANIAN MEDICINE, 2016, 19 (07) : 508 - 517
  • [30] Non-coding RNAs as potential biomarkers in osteosarcoma
    Fan, Lijuan
    Zhong, Zhenhao
    Lin, Yubo
    Li, Jitian
    FRONTIERS IN GENETICS, 2022, 13